Antimicrobial lock solutions for the prevention of catheter-related infection in patients undergoing haemodialysis: Study protocol for network metaanalysis of randomised controlled trials

Jun Zhang, Rong Ke Li, Kee Hsin Chen, Long Ge, Jin Hui Tian

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Catheter-related infection (CRI) is a difficult clinical problem in renal medicine, with blood stream infections occurring in up to 40% of patients with haemodialysis (HD) catheters, conferring significant rates of morbidity and mortality. Several approaches have been assessed as a means to prevent CRI. Currently, an intervention that is the source of much discussion is the use of antimicrobial lock solutions (ALS). A number of past conventional metaanalyses have compared different ALS with heparin. However, there is no consensus recommendation regarding which type of ALS is best. The purpose of our study is to carry out a network meta-analysis comparing the efficacy of different ALS for prevention of CRI in patients with HD and ranking these ALS for practical consideration. Methods and analysis: We will search six electronic databases, earlier relevant meta-analyses and reference lists of included studies for randomised controlled trials (RCTs) that compared ALS for preventing episodes of CRI in patients with HD either head-tohead or against control interventions using non-ALS. Study selection and data collection will be performed by two reviewers independently. The Cochrane Risk of Bias Tool will be used to assess the quality of included studies. The primary outcome of efficacy will be catheter-related bloodstream infection (CRBSI). We will perform a Bayesian network meta-analysis to compare the relative efficacy of different ALS by WinBUGS (V.1.4.3) and STATA (V.13.0). The quality of evidence will be assessed by GRADE. Ethics and dissemination: Ethical approval is not required given that this study includes no confidential personal data and no data on interventions on patients. The results of this study will be submitted to a peerreview journal for publication. Trial registration number: CRD42015027010.

Original languageEnglish
Article numbere010264
JournalBMJ Open
Volume6
Issue number1
DOIs
Publication statusPublished - Jan 2016

Fingerprint

Catheter-Related Infections
Renal Dialysis
Randomized Controlled Trials
Ethics
Heparin
Publications
Meta-Analysis
Catheters
Head
Medicine
Databases
Morbidity
Kidney
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antimicrobial lock solutions for the prevention of catheter-related infection in patients undergoing haemodialysis : Study protocol for network metaanalysis of randomised controlled trials. / Zhang, Jun; Li, Rong Ke; Chen, Kee Hsin; Ge, Long; Tian, Jin Hui.

In: BMJ Open, Vol. 6, No. 1, e010264, 01.2016.

Research output: Contribution to journalArticle

@article{e3a21afbb66742bcbba3126a5d6fca72,
title = "Antimicrobial lock solutions for the prevention of catheter-related infection in patients undergoing haemodialysis: Study protocol for network metaanalysis of randomised controlled trials",
abstract = "Introduction: Catheter-related infection (CRI) is a difficult clinical problem in renal medicine, with blood stream infections occurring in up to 40{\%} of patients with haemodialysis (HD) catheters, conferring significant rates of morbidity and mortality. Several approaches have been assessed as a means to prevent CRI. Currently, an intervention that is the source of much discussion is the use of antimicrobial lock solutions (ALS). A number of past conventional metaanalyses have compared different ALS with heparin. However, there is no consensus recommendation regarding which type of ALS is best. The purpose of our study is to carry out a network meta-analysis comparing the efficacy of different ALS for prevention of CRI in patients with HD and ranking these ALS for practical consideration. Methods and analysis: We will search six electronic databases, earlier relevant meta-analyses and reference lists of included studies for randomised controlled trials (RCTs) that compared ALS for preventing episodes of CRI in patients with HD either head-tohead or against control interventions using non-ALS. Study selection and data collection will be performed by two reviewers independently. The Cochrane Risk of Bias Tool will be used to assess the quality of included studies. The primary outcome of efficacy will be catheter-related bloodstream infection (CRBSI). We will perform a Bayesian network meta-analysis to compare the relative efficacy of different ALS by WinBUGS (V.1.4.3) and STATA (V.13.0). The quality of evidence will be assessed by GRADE. Ethics and dissemination: Ethical approval is not required given that this study includes no confidential personal data and no data on interventions on patients. The results of this study will be submitted to a peerreview journal for publication. Trial registration number: CRD42015027010.",
author = "Jun Zhang and Li, {Rong Ke} and Chen, {Kee Hsin} and Long Ge and Tian, {Jin Hui}",
year = "2016",
month = "1",
doi = "10.1136/bmjopen-2015-010264",
language = "English",
volume = "6",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Antimicrobial lock solutions for the prevention of catheter-related infection in patients undergoing haemodialysis

T2 - Study protocol for network metaanalysis of randomised controlled trials

AU - Zhang, Jun

AU - Li, Rong Ke

AU - Chen, Kee Hsin

AU - Ge, Long

AU - Tian, Jin Hui

PY - 2016/1

Y1 - 2016/1

N2 - Introduction: Catheter-related infection (CRI) is a difficult clinical problem in renal medicine, with blood stream infections occurring in up to 40% of patients with haemodialysis (HD) catheters, conferring significant rates of morbidity and mortality. Several approaches have been assessed as a means to prevent CRI. Currently, an intervention that is the source of much discussion is the use of antimicrobial lock solutions (ALS). A number of past conventional metaanalyses have compared different ALS with heparin. However, there is no consensus recommendation regarding which type of ALS is best. The purpose of our study is to carry out a network meta-analysis comparing the efficacy of different ALS for prevention of CRI in patients with HD and ranking these ALS for practical consideration. Methods and analysis: We will search six electronic databases, earlier relevant meta-analyses and reference lists of included studies for randomised controlled trials (RCTs) that compared ALS for preventing episodes of CRI in patients with HD either head-tohead or against control interventions using non-ALS. Study selection and data collection will be performed by two reviewers independently. The Cochrane Risk of Bias Tool will be used to assess the quality of included studies. The primary outcome of efficacy will be catheter-related bloodstream infection (CRBSI). We will perform a Bayesian network meta-analysis to compare the relative efficacy of different ALS by WinBUGS (V.1.4.3) and STATA (V.13.0). The quality of evidence will be assessed by GRADE. Ethics and dissemination: Ethical approval is not required given that this study includes no confidential personal data and no data on interventions on patients. The results of this study will be submitted to a peerreview journal for publication. Trial registration number: CRD42015027010.

AB - Introduction: Catheter-related infection (CRI) is a difficult clinical problem in renal medicine, with blood stream infections occurring in up to 40% of patients with haemodialysis (HD) catheters, conferring significant rates of morbidity and mortality. Several approaches have been assessed as a means to prevent CRI. Currently, an intervention that is the source of much discussion is the use of antimicrobial lock solutions (ALS). A number of past conventional metaanalyses have compared different ALS with heparin. However, there is no consensus recommendation regarding which type of ALS is best. The purpose of our study is to carry out a network meta-analysis comparing the efficacy of different ALS for prevention of CRI in patients with HD and ranking these ALS for practical consideration. Methods and analysis: We will search six electronic databases, earlier relevant meta-analyses and reference lists of included studies for randomised controlled trials (RCTs) that compared ALS for preventing episodes of CRI in patients with HD either head-tohead or against control interventions using non-ALS. Study selection and data collection will be performed by two reviewers independently. The Cochrane Risk of Bias Tool will be used to assess the quality of included studies. The primary outcome of efficacy will be catheter-related bloodstream infection (CRBSI). We will perform a Bayesian network meta-analysis to compare the relative efficacy of different ALS by WinBUGS (V.1.4.3) and STATA (V.13.0). The quality of evidence will be assessed by GRADE. Ethics and dissemination: Ethical approval is not required given that this study includes no confidential personal data and no data on interventions on patients. The results of this study will be submitted to a peerreview journal for publication. Trial registration number: CRD42015027010.

UR - http://www.scopus.com/inward/record.url?scp=84960396674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960396674&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2015-010264

DO - 10.1136/bmjopen-2015-010264

M3 - Article

AN - SCOPUS:84960396674

VL - 6

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 1

M1 - e010264

ER -